You have 9 free searches left this month | for more free features.

Pretreatment anti-therapeutic antibodies (PATA)

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pretreatment Anti-Therapeutic Antibodies in Patients Treated

Completed
  • Ewing Family of Tumors
  • +3 more
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Nov 4, 2020

    Isolation of Human Recombinant Therapeutic Monoclonal

    Recruiting
    • Pseudomonas Aeruginosa
    • Multi-antibiotic Resistance
    • Isolation of anti-Pseudomonas antibodies from type B lymphocytes
    • Grenoble, France
      Chu Grenoble Alpes
    May 6, 2022

    COVID-19 Trial in Bruxelles (Evolution of antibodies titre)

    Recruiting
    • COVID-19
    • Evolution of antibodies titre
    • Bruxelles, International, Belgium
      Cliniques universitaires Saint-Luc
    Jan 12, 2022

    Psoriasis Vulgaris Trial in Ghent (Venapuncture, Patient questionnaires)

    Recruiting
    • Psoriasis Vulgaris
    • Venapuncture
    • Patient questionnaires
    • Ghent, East-Flanders, Belgium
    • +1 more
    Jan 5, 2023

    Psoriasis Vulgaris Trial in Belgium (Venapuncture, Patient questionnaires)

    Recruiting
    • Psoriasis Vulgaris
    • Venapuncture
    • Patient questionnaires
    • Ghent, East-Flanders, Belgium
    • +6 more
    Jan 16, 2023

    Psoriasis Vulgaris Trial in Belgium (Venapuncture, Patient questionnaires)

    Recruiting
    • Psoriasis Vulgaris
    • Venapuncture
    • Patient questionnaires
    • Ghent, Oost-Vlaanderen, Belgium
    • +6 more
    Jan 16, 2023

    Psoriasis Vulgaris Trial in Belgium (Venapuncture, Patient questionnaires)

    Recruiting
    • Psoriasis Vulgaris
    • Venapuncture
    • Patient questionnaires
    • Ghent, East-Flanders, Belgium
    • +6 more
    Jan 5, 2023

    Psoriasis Vulgaris Trial in Belgium (Venapuncture, Patient questionnaires)

    Recruiting
    • Psoriasis Vulgaris
    • Venapuncture
    • Patient questionnaires
    • Ghent, East-Flanders, Belgium
    • +6 more
    Jan 16, 2023

    Psoriasis Vulgaris Trial in Belgium (Venapuncture, Patient questionnaires)

    Recruiting
    • Psoriasis Vulgaris
    • Venapuncture
    • Patient questionnaires
    • Ghent, Oost-Vlaanderen, Belgium
    • +6 more
    Jan 16, 2023

    Pure Autonomic Failure, Amyotrophic Lateral Sclerosis, Postural Orthostatic Tachycardia Syndrome Trial in Rozzano

    Completed
    • Pure Autonomic Failure
    • +3 more
    • Immunoabsorption/plasmapheresis procedure
    • Rozzano, Italy
      Humanitas Research Hospital
    May 3, 2021

    Ganglioneuroblastoma, High Risk Neuroblastoma Trial in Australia, New Zealand, United States (procedure, drug, biological,

    Active, not recruiting
    • Ganglioneuroblastoma
    • High Risk Neuroblastoma
    • Autologous Hematopoietic Stem Cell Transplantation
    • +14 more
    • Los Angeles, California
    • +9 more
    Sep 1, 2022

    HLA-DQA1*05 Genotype in Anti-TNF Treatment With Proactive

    Recruiting
    • Drug Monitoring
    • Inflammatory Bowel Diseases
    • Tumor necrosis factor (TNF)-alpha inhibitors
    • Valladolid, Spain
      Hospital Universitario Rio Hortega
    Aug 8, 2023

    Crohn's Disease, Ulcerative Colitis Trial in Montpellier (Immuno monitoring)

    Completed
    • Crohn's Disease
    • Ulcerative Colitis
    • Immuno monitoring
    • Montpellier, France
      University hospital
    Dec 13, 2022

    Neuropathy and Anti-GFAP Antibodies

    Active, not recruiting
    • Neurological Diseases or Conditions
    • Neurological Diseases Associated to Anti GFAP Antibodies
    • Clinical examination
    • electroneuromyography (ENMG)
    • Lyon, France
      Centre de référence des syndromes neurologiques paranéoplasiques
    Feb 14, 2023

    Metastatic Colorectal Cancer Trial in Worldwide (RO7122290, Cibisatamab, Obinutuzumab)

    Recruiting
    • Metastatic Colorectal Cancer
    • Toronto, Ontario, Canada
    • +15 more
    Jan 13, 2023

    Therapeutic Monitoring of Infliximab and Adalimumab

    Recruiting
    • Inflammatory Bowel Diseases
    • Trieste, Italy
      IRCCS Burlo Garofolo
    Sep 5, 2023

    Hypersensitivity, Immediate, Peri-operative Injury, Antibiotic Allergy Trial in Paris (IgG group, IgE group, IgG group + IgE

    Not yet recruiting
    • Hypersensitivity, Immediate
    • +3 more
    • IgG group
    • +2 more
    • Paris, France
      Hôpital Bichat claude Bernard
    Jun 10, 2022

    Immunocompromised Trial in Mexico, United States (casirivimab+imdevimab, Placebo)

    Terminated
    • Immunocompromised
    • Birmingham, Alabama
    • +66 more
    Jul 26, 2022

    Metformin, Prediabetes, In-Vitro Fertilization Trial in Jinan (Metformin pretreatment before ovarian stimulation, Placebo

    Not yet recruiting
    • Metformin
    • +2 more
    • Metformin pretreatment before ovarian stimulation
    • +3 more
    • Jinan, Shandong, China
      Shandong University
    Sep 26, 2023

    Rheumatoid Arthritis Trial in Boston (Therapeutic drug monitoring (TDM))

    Not yet recruiting
    • Rheumatoid Arthritis
    • Therapeutic drug monitoring (TDM)
    • Boston, Massachusetts
      Boston Medical Center, Rheumatology Clinic
    Jul 13, 2022

    Anti-NMDAR Encephalitis Trial in Paris (IA session, Rituximab)

    Recruiting
    • Anti-NMDAR Encephalitis
    • Paris, France
      Hôpital Necker Enfants-Malades
    Oct 31, 2022

    Upper Aero-intestinal Tract Cancer, Supraclavicular Flap, Anterior Thoracic Perforator Artery Trial in Lyon (Doppler ultrasound)

    Recruiting
    • Upper Aero-intestinal Tract Cancer
    • +2 more
    • Doppler ultrasound
    • Lyon, France
      Hôpital Privé Jean Mermoz
    Nov 14, 2023

    Colorectal Cancer, Hepatic Metastases Trial in Tours (radiation, other, drug)

    Completed
    • Colorectal Cancer
    • Hepatic Metastases
    • MRI
    • +3 more
    • Tours, France
      Service d'Hépatogastro-entérologie CHRU de TOURS
    Jan 6, 2023

    Obstetrical History and Anti-HLA Antibodies Level

    Not yet recruiting
    • Blood Donors
    • Anti-HLA Antibody
    • Obstetrical history
    • Anti-HLA Antibody tests
    • Bordeaux, France
      Etablissement Français du Sang Nouvelle Aquitaine
    Aug 25, 2023

    Combined TACE, TKI/Anti-VEGF and ICIs as Conversion Therapy for

    Recruiting
    • Hepatocellular Carcinoma Non-resectable
    • TACE
    • +8 more
    • Quanzhou, Fujian, China
    • +3 more
    Jan 29, 2023